Heart Test Laboratories Inc. Common Stock
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting… Read more
Market Cap & Net Worth: Heart Test Laboratories Inc. Common Stock (HSCS)
Heart Test Laboratories Inc. Common Stock (NASDAQ:HSCS) has a market capitalization of $8.42 Million ($8.42 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29455 globally and #9760 in its home market, demonstrating a -0.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Heart Test Laboratories Inc. Common Stock's stock price $2.65 by its total outstanding shares 3178207 (3.18 Million).
Heart Test Laboratories Inc. Common Stock Market Cap History: 2022 to 2026
Heart Test Laboratories Inc. Common Stock's market capitalization history from 2022 to 2026. Data shows change from $266.94 Million to $8.42 Million (-66.97% CAGR).
Index Memberships
Heart Test Laboratories Inc. Common Stock is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #763 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2440 of 3165 |
Weight: Heart Test Laboratories Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Heart Test Laboratories Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Heart Test Laboratories Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2257.62x
Heart Test Laboratories Inc. Common Stock's market cap is 2257.62 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $266.94 Million | $14.37K | -$4.83 Million | 18572.13x | N/A |
| 2023 | $54.35 Million | $5.15K | -$6.35 Million | 10552.88x | N/A |
| 2024 | $12.14 Million | $18.60K | -$6.61 Million | 652.73x | N/A |
| 2025 | $9.82 Million | $4.35K | -$8.77 Million | 2257.62x | N/A |
Competitor Companies of HSCS by Market Capitalization
Companies near Heart Test Laboratories Inc. Common Stock in the global market cap rankings as of March 18, 2026.
Key companies related to Heart Test Laboratories Inc. Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Heart Test Laboratories Inc. Common Stock Historical Marketcap From 2022 to 2026
Between 2022 and today, Heart Test Laboratories Inc. Common Stock's market cap moved from $266.94 Million to $ 8.42 Million, with a yearly change of -66.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.42 Million | -14.24% |
| 2025 | $9.82 Million | -19.11% |
| 2024 | $12.14 Million | -77.66% |
| 2023 | $54.35 Million | -79.64% |
| 2022 | $266.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Heart Test Laboratories Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.42 Million USD |
| MoneyControl | $8.42 Million USD |
| MarketWatch | $8.42 Million USD |
| marketcap.company | $8.42 Million USD |
| Reuters | $8.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.